Sukhatme Mayukh

CIK 00017500501 companyLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001750050

Recent Transactions

21 trades

Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17−59,513→ 1,304,198 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$12.68/sh+59,513→ 18,896,060 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$23.09/sh−26,831→ 18,869,229 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$23.09/sh−32,682→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-12-26−689,495→ 15,224,363 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-26$12.01/sh−689,495→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-26$3.85/sh+689,495→ 19,526,042 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-24$12.00/sh−185,946→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-24$3.85/sh+185,946→ 19,022,493 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-12-24−185,946→ 15,913,858 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-23$3.85/sh+10,796→ 18,847,343 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-12-23−10,796→ 16,099,804 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-23$12.00/sh−10,796→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-18$3.85/sh+412,584→ 19,249,131 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-18$12.05/sh−412,584→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-12-18−412,584→ 16,110,600 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-03$12.21/sh−3,651,985→ 18,836,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-08-27+22,565→ 3,189,960 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-08-27$6.40/sh−53,033→ 2,068,296 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-07-27$6.40/sh−106,067→ 2,121,329 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-07-27+43,212→ 3,167,395 total

Companies

Roivant Sciences Ltd.
Director, Pres&Chief Investment Officer
$ROIV

Recent Filings

Address

C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY

LONDON, X0, SW1H 0DB

View on SEC.gov